JAZZ · Company research
Jazz Pharmaceuticals, Inc. (JAZZ): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 231.19 | $16,536,632,000 | 14916832000.00 | 85.7122302158273381 | — | — | 13.6858660928577340 | 3.4439119478518025 | 41.5911267605633805 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.